STVN
Stevanato Group S.p.A. · Healthcare · Medical - Instruments & Supplies
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 48 | -4 | 20.53M | $371.04M | +4 | −9 |
| Q1 2026 | 53 | +5 | 19.12M | $262.92M | +9 | −5 |
| Q4 2025 | 49 | +2 | 19.36M | $389.64M | +4 | −1 |
| Q3 2025 | 7 | -1 | 947.89K | $24.41M | +1 | −2 |
| Q2 2025 | 6 | 0 | 762.00K | $18.63M | — | — |
| Q1 2025 | 4 | 0 | 658.83K | $13.45M | — | — |
| Q4 2024 | 4 | 0 | 631.98K | $13.77M | +1 | −1 |
| Q3 2024 | 3 | 0 | 2.86M | $57.24M | +1 | −1 |
| Q2 2024 | 3 | — | 2.71M | $49.64M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.69M | +4.5% | $53.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.69M | +4.5% | $53.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.69M | +4.5% | $53.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.69M | +4.5% | $53.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.69M | +4.5% | $53.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.69M | +4.5% | $53.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 156.15K | New | $3.12M | 0.0% | New | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 156.15K | New | $3.12M | 0.0% | New | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 12.39K | -88.5% | $247,820 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $3.12M | 0.0% |
| Marshall Wace | $3.12M | 0.0% |
Exited
| D. E. Shaw & Co. | $374,980 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 133 holders, 44.55M shares, $562.53M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 4.21K sh · $84,559
Director · 2.04K sh · $41,084
Director · 2.02K sh · $40,642
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology